Ligand Pharmaceuticals

LGND

Market cap $4.45B

Buy

Hold

Sell

3 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target

Avg. target

$253

13% upside

High target

positive

0 neutral

negative

Analyst & Firm	Rating	Price Target	Upside Downside	Date
BofA Securities Jason Zemansky 0% 1-yr LGND win rate				11 Mar ‘26 1 month ago
Oppenheimer Trevor Allred 100% 1-yr LGND win rate				27 Feb ‘26 1 month ago
HC Wainwright & Co Joseph Pantginis 67% 1-yr LGND win rate				24 Feb ‘26 1 month ago